Impact of Interval to Esophagectomy After Neoadjuvant Immunochemotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma: A Multicenter Retrospective Cohort Analysis
Patients demonstrated tolerance for esophagectomy within 4-6 weeks after nICT. Based on the present findings regarding pCR, DFS, and OS, extending the time to surgery beyond 6 weeks was found to be acceptable.
Authors
- Zhi-Nuan Hong (ORCID: https://orcid.org/0000-0002-1800-6158)
- Shuhan Xie
- Kaiming Peng
- Mingduan Chen
- Jihong Lin
- Sunkui Ke
- Shuchen Chen (ORCID: https://orcid.org/0000-0002-3316-9908)
- Ziyang Han
- Peipei Zhang (ORCID: https://orcid.org/0000-0002-3986-9075)
- Hui Xu (ORCID: https://orcid.org/0000-0003-1242-5973)
- Zhen Chen (ORCID: https://orcid.org/0000-0003-3949-5744)
- Lin Ye
- Jinxin Xu (ORCID: https://orcid.org/0000-0001-5399-4633)
- Jinbiao Xie (ORCID: https://orcid.org/0000-0002-4021-9504)
- Dinghang Chen
Institutions
- Fujian Medical University (CN)
- Zhongshan Hospital of Xiamen University (CN)
- Union Hospital (CN)
- Putian University (CN)
Publication Details
- Journal
- Thoracic Cancer
- Published
- 2025-03-01
- DOI
- https://doi.org/10.1111/1759-7714.70019
- Primary Topic
- Esophageal Cancer Research and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China